Skip to main content

Streptococcus gallolyticus Spurs Colorectal Tumor Growth in Mice

The bacteria also promoted the growth of human colon cancer cells in a dish.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

BRYAN SATALINOScientists have long known of the link between the bacteria Streptococcus gallolyticus and colorectal cancer (CRC) in humans—numerous case studies have reported instances of patients with S. gallolyticus infections who also have CRC. How this microbe contributes to the cancer, however, was unclear. Now, a new study, published yesterday (July 13) in PLOS Pathogens, suggests that S. gallolyticus may speed up the growth of colon tumors.

To investigate the link between S. gallolyticus and colon cancer, a team of scientists investigated cultured human cells, human tumor tissue, and colon-cancer-prone mice.

The cell culture experiments revealed that three types of colon cancer cells grown with S. gallolyticus multiplied more rapidly than those cultured with Lactococcus lactis, a type of bacteria used to ferment milk, or with no bacteria at all. S. gallolyticus had no effect on normal colon cells, kidney cells, lung cancer cells, and two other strains of colon cancer cells.

The selective effects of S. gallolyticus point to the possibility that this bacterium doesn’t promote the growth of all types of colon cancer, Cynthia Sears, an infectious disease specialist at Johns Hopkins University School of Medicine who was not involved ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays